Blog - Page 928 of 5753 - QualityStocks

WednesdaySep 28, 2022 3:12 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Leveraging LN to Enhance Micropayment Experience

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), is leveraging the LN in pursuit of expanding the capabilities of Bitcoin. “Several countries worldwide have used the LN to their advantage, opening up payment opportunities that would not have existed otherwise. Last year, El Salvador adopted Bitcoin as a legal tender, using the LN’s capabilities to process millions of transactions to facilitate the purchase of everyday goods… Other countries are making Bitcoin payment more accessible, adding payment options in the cryptocurrency to everyday transactions,” a recent article…

WednesdaySep 28, 2022 3:03 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Results from Annual Meeting

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced voting results in connection with the annual and special meeting of the company's shareholders, which was held virtually on Sept. 27, 2022. According to the announcement, a total of 31,830,069 common shares representing 45.55% of the company’s issued and outstanding common shares were voted in connection with the meeting. Shareholders voted in favor of the election of the six director nominees as well as other items of business, including the re-appointment of RSM Canada LLP as the company’s auditors, the adoption of new company by-laws, and the approval of the…

WednesdaySep 28, 2022 2:02 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Activates First European Sites for Potentially Pivotal Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. According to the update, the first European clinical trial sites in France and Spain are now open and actively enrolling patients. “Our primary focus continues to be on advancing the clinical development of…

WednesdaySep 28, 2022 1:50 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow Makes Ohio Stop

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, is slated for a visit in New Albany, Ohio, on Sept. 29, 2022. The company’s Robot Roadshow is a creative event designed to provide hands-on experiences for those interested in its Autonomous Security Robots (“ASRs”). The unique event is an engaging experiential event for potential clients that grabs attention, forges direct connections and sparks conversations. So far, the roadshow has made 59 stops in 23 states and Washington, DC. The event features a tour of Knightscope’s crime-fighting robots. The robots travel in a space-age,…

WednesdaySep 28, 2022 1:25 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Announces Successful Completion of Phase I Clinical Trial for PRV-002

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, today announced the completion of all cohorts for its Phase I Single Ascending Dosing (“SAD”) and Multiple Ascending Dosing (“MAD”) clinical trial. Odyssey’s trial involved administering its novel drug to treat concussion, PRV-002, to healthy human subjects. The drug was safe and well tolerated throughout the trial. “After reviewing the data from each of the cohorts, I have strong confidence that it is safe to proceed to the next clinical trial phase where PRV-002 will be administered for 10 consecutive days to subjects following concussion,” said Dallas…

WednesdaySep 28, 2022 12:07 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Technology Enabling 12-Lead ECG Receives Patent from USPTO

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, has been granted a patent from the United States Patent and Trademark Office (“USPTO”). The patent covers proprietary technology that allows the HeartBeam AIMIGo(TM) credit card-sized device to enable a 12-lead ECG anytime or anywhere. According to the announcement, the innovative tech and AIMIGo device makes it possible for a patient to record signals outside of a medical setting with a diagnostic synthesized 12-lead ECG that is immediately transmitted to a physician for review and diagnosis; the now-patented…

WednesdaySep 28, 2022 11:55 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Focus on Launch of Proprietary UST Processing Method in Emerging Growth Conference Presentation

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing services to the worldwide life sciences, nutraceuticals, cosmetics, food and beverage, and other key industries, is presenting at today’s Emerging Growth Investor Conference. The conference has built a reputation for being an effective way for publicly traded companies to present and communicate new products and services as well as other major announcements to thousands of individual and institutional investors and investment advisors and analysts. PBI president and CEO Richard T. Schumacher spoke at 9 a.m. ET; the focus of…

WednesdaySep 28, 2022 11:24 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases New Info about Upcoming Mullen Five RS

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced an upcoming version of its Mullen Five crossover that delivers a performance “to rival Plaid versions of Tesla’s Model S and Model X.” The Mullen Five was originally meant to compete against Tesla’s Model Y and Volkswagen ID.4, but the new version features more than 1,000 horsepower and the ability to go from 0 to 60 in under 2 seconds with a top speed of more than 200 mph; the new model also features an 800-volt electrical system, enabling rapid charge times when using a DC fast charger. The…

WednesdaySep 28, 2022 11:15 am

DGE 6th Digital Strategy & Innovation For Medical Affairs Summit

Life science and health care professionals, as well as consumers, are invited to attend the 6th Digital Strategy & Innovation for Medical Affairs Summit on November 2-3, 2022. Participating pharma and medical companies can learn how to streamline their medical department affairs using innovative digital transformation policies that experts share and discuss at the DGE event. The event is organized by Dynamic Global Events (“DGE”), a leading life science B2B event organizing company. The 6th Digital Strategy Summit is the largest event devoted to the medical industry that is being streamed live on an established interactive platform. The event will…

WednesdaySep 28, 2022 10:30 am

DX3 USA 2022 – The Retail, Marketing and Technology Event Forays Into US Territories

Join thought leaders and dignitaries from the retail, marketing, and tech industries, as they offer important insights, with workshops, on how the retail and marketing sector should embrace the evolving technologies. Discover innovative solutions at the DX3 USA 2022 on October 3-4, 2022, being live streamed as a live streaming virtual event. DX3 is a leading event management enterprise organizing conferences and trade shows that bring industries, executives, and professionals from the retail, marketing, and technology fields together in a common forum. Having proven its mettle in Canada for 11 years, DX3 now enters the US markets to define, understand,…

Site Search

Company Search